載入...
Immune checkpoint inhibitor—related dermatologic adverse events
Immune checkpoint inhibitors have emerged as a pillar in the management of advanced malignancies. However, nonspecific immune activation may lead to immune-related adverse events, wherein the skin and its appendages are the most frequent targets. Cutaneous immune-related adverse events include a div...
Na minha lista:
| 發表在: | J Am Acad Dermatol |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7572894/ https://ncbi.nlm.nih.gov/pubmed/32454097 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaad.2020.03.132 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|